AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimijoy MV 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Vjovis Health Care Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glimijoy MV 2mg/500mg/0.3mg Tablet

Diabetic patients may find relief with the triple-action formulation of Glimepiride/Metformin/Voglibose 2mg/500mg/0.3mg tablets. This medication, classified as an anti-diabetic agent, effectively manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal results. Dosage will be personalized by your physician and adjusted as needed based on blood sugar monitoring. Continued use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication is only one component of a comprehensive diabetes management plan, encompassing dietary adjustments, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices are paramount in diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, manifesting as sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods, fruit juice) is essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before initiating treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Uses of Glimijoy MV 2mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Glimijoy MV 2mg/500mg/0.3mg Tablet:

Consume Glimijoy MV 2mg/500mg/0.3mg tablets precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. Administration should be on an empty stomach.

Common Side effects of Glimijoy MV 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimijoy MV 2mg/500mg/0.3mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Glimijoy MV 2mg/500mg/0.3mg tablets on an empty stomach.

How Glimijoy MV 2mg/500mg/0.3mg Tablet works:

Glimijoy MV 2mg/500mg/0.3mg tablets contain a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimijoy MV 2mg/500mg/0.3mg tablets with alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glimijoy MV 2mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against the risks before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Glimijoy MV 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Glimijoy MV 2mg/500mg/0.3mg Tablets due to potential safety concerns. Medical advice is necessary. The use of Glimijoy MV 2mg/500mg/0.3mg Tablets is contraindicated in those with severe kidney impairment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimijoy MV 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimijoy MV 2mg/500mg/0.3mg Tablet :

Should you forget to take your Glimijoy MV 2mg/500mg/0.3mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimijoy MV 2mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimijoy MV 2mg/500mg/0.3mg Tablet

Glimijoy MV 2mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is unsuitable for type 1 DM.
Glimijoy MV 2mg/500mg/0.3mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, stomach pain, headache, rash, and respiratory infection.
Glimijoy MV 2mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any ingredient. Avoid use in those with moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Glimijoy MV 2mg/500mg/0.3mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimijoy MV 2mg/500mg/0.3mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medicine; keep it out of reach of children, pets, and others.
Glimijoy MV 2mg/500mg/0.3...
121
MRP 140
13% off